Tenax Therapeutics, Inc. (TENX)
1.98
+0.05
(+2.59%)
USD |
NASDAQ |
Oct 02, 16:00
1.97
-0.01
(-0.51%)
After-Hours: 20:00
Tenax Therapeutics Net Income (Quarterly) : -17.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.80M |
| March 31, 2026 | -15.72M |
| December 31, 2025 | -15.54M |
| September 30, 2025 | -15.80M |
| June 30, 2025 | -10.85M |
| March 31, 2025 | -10.41M |
| December 31, 2024 | -6.267M |
| September 30, 2024 | -3.960M |
| June 30, 2024 | -3.576M |
| March 31, 2024 | -3.799M |
| December 31, 2023 | -3.226M |
| September 30, 2023 | -1.972M |
| June 30, 2023 | -1.106M |
| March 31, 2023 | -1.407M |
| December 31, 2022 | -2.549M |
| September 30, 2022 | -2.916M |
| June 30, 2022 | -2.861M |
| March 31, 2022 | -2.722M |
| December 31, 2021 | -3.211M |
| September 30, 2021 | -3.799M |
| June 30, 2021 | -1.717M |
| March 31, 2021 | -23.75M |
| December 31, 2020 | -2.830M |
| September 30, 2020 | -2.220M |
| June 30, 2020 | -2.147M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.655M |
| December 31, 2019 | -2.792M |
| September 30, 2019 | -2.224M |
| June 30, 2019 | -1.762M |
| March 31, 2019 | -1.617M |
| December 31, 2018 | -2.231M |
| September 30, 2018 | -1.536M |
| June 30, 2018 | -1.868M |
| March 31, 2018 | -1.193M |
| December 31, 2017 | -1.344M |
| September 30, 2017 | -1.234M |
| June 30, 2017 | -2.986M |
| March 31, 2017 | -3.276M |
| December 31, 2016 | -29.65M |
| September 30, 2016 | -4.274M |
| June 30, 2016 | -4.641M |
| July 31, 2015 | -3.034M |
| April 30, 2015 | -4.987M |
| January 31, 2015 | -2.868M |
| October 31, 2014 | -4.055M |
| July 31, 2014 | -2.171M |
| April 30, 2014 | -10.41M |
| January 31, 2014 | -3.351M |
| October 31, 2013 | -3.532M |
| July 31, 2013 | -2.245M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Exicure, Inc. | -1.121M |
| Century Therapeutics, Inc. | -34.55M |
| Absci Corp. | -33.21M |
| Celularity, Inc. | 0.675M |
| Cardio Diagnostics Holdings, Inc. | -1.502M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 17.80M |
| EPS Diluted (Quarterly) | -0.35 |
| Enterprise Value | -54.72M |
| Earnings Yield | -74.49% |
| Normalized Earnings Yield | -74.49 |